Teva stock plunged Wednesday — sacrificing an earlier breakout — despite beating Wall Street's third-quarter expectations and raising its guidance.Please watch the video at Investors.com - How Novo ...

JERUSALEM (Reuters) - Teva Pharmaceutical Industries expects to work productively with the incoming Trump administration in ...

Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance after beating third-quarter profit forecasts, ...

Operator Hello, and welcome to the Q3 2024 Teva Pharmaceuticals Industries Limited earnings conference call. My name is Alex, ...

As other biopharma giants have divested their generics units to focus on the development and commercialization of innovative ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported third-quarter 2024 sales of $4.33 billion on Wednesday. It beat the ...

Teva Pharmaceuticals' strategic turnaround delivers massive gains--13% revenue jump and higher 2024 guidance ignite market ...

Reports Q3 revenue $4.3B, consensus $4.12B. Richard Francis, Teva‘s (TEVA) President and CEO, said, “The third quarter of 2024 ...

In the first nine months of 2024, Teva reported revenue of $12.3 billion, up 8.1% from the corresponding period of last year.

The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly ...

On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its ...